Related Experiment Video

Updated: May 2, 2026

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

14.7K

Effect of small-molecule modification on single-cell pharmacokinetics of PARP inhibitors

Greg M Thurber1, Thomas Reiner, Katherine S Yang

  • 1Authors' Affiliations: Center for Systems Biology, Massachusetts General Hospital; and Department of Systems Biology, Harvard Medical School, Boston, Massachusetts.

Molecular Cancer Therapeutics
|February 21, 2014
PubMed

Insights

Researchers developed fluorescent drug probes to visualize drug distribution in tumors with high resolution. This method overcomes limitations of traditional techniques, enabling better understanding of drug delivery for improved cancer therapeutics.

Area of Science:

  • Pharmacology
  • Biomedical Engineering
  • Cancer Research

Background:

  • Tumor drug delivery is heterogeneous, impacting treatment efficacy.
  • Studying drug distribution in complex tumor microenvironments is challenging.
  • Existing methods lack spatial and temporal resolution for small-molecule drugs.

Purpose of the Study:

  • To develop novel fluorescent drug conjugates for high-resolution drug distribution studies.
  • To overcome limitations of traditional detection methods for in vivo drug kinetics.
  • To enable predictive pharmacokinetic modeling for therapeutic design.

Main Methods:

  • Synthesis of fluorescent drug conjugates with varied pharmacokinetic properties.
  • Real-time tracking of drug distribution in cell culture and tumor xenografts.
  • Utilizing subcellular spatial and second-level temporal resolution imaging.

Main Results:

  • Demonstrated high spatial and temporal resolution of drug distribution.
  • Quantified in vivo permeability of small-molecule drugs.
  • Validated the utility of fluorescent probes in predictive pharmacokinetic models.

Conclusions:

  • Fluorescent drug conjugates offer unprecedented insight into drug delivery dynamics.
  • This approach facilitates the design of targeted therapeutics and companion imaging agents.
  • Predictive pharmacokinetic models can be enhanced by high-resolution drug distribution data.

More Related Videos

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC Crosslinking of Small Molecules to Isolate Chromatin10:05

Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC Crosslinking of Small Molecules to Isolate Chromatin

Published on: January 20, 2016

7.7K
Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

8.8K

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
928
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
194
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
138
Nonlinear Pharmacokinetics: Role of Transporters01:27

Nonlinear Pharmacokinetics: Role of Transporters

A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
398